Abstract

BackgroundIn patients with differentiated thyroid cancer (DTC), serial 124I PET/CT imaging is, for instance, used to assess the absorbed (radiation) dose to lesions. Frequently, the lesions are located in the neck and they are close to or surrounded by different tissue types. In contrast to PET/CT, MR-based attenuation correction in PET/MR may be therefore challenging in the neck region. The aim of this retrospective study was to assess the quantitative performance of 124I PET/MRI of neck lesions by comparing the MR-based and CT-based 124I activity concentrations (ACs). Sixteen DTC patients underwent PET/CT scans at 24 and 120 h after administration of about 25 MBq 124I. Approximately 1 h before or after PET/CT examination, each patient additionally received a 24-h PET/MR scan and sometimes a 120-h PET/MR scan. PET images were reconstructed using the respective attenuation correction approach. Appropriate reconstruction parameters and corrections were used to harmonize the reconstructed PET images to provide, for instance, similar spatial resolution. For each lesion, two types of ACs were ascertained: the maximum AC (max-AC) and an average AC (avg-AC). The avg-AC is the average activity concentration obtained within a spherical volume of interest with a diameter of 7 mm, equaling the PET scanner resolution. For each type of AC, the percentage AC difference between MR-based and CT-based ACs was determined and Lin’s concordance correlation analysis was applied. Quantitative performance was considered acceptable if the standard deviation was ± 25% (precision), and the mean value was within ± 10% (accuracy).ResultsThe avg-ACs (max-ACs within parentheses) of 74 lesions ranged from 0.20 (0.33) to 657 (733) kBq/mL. Excluding two lesions with ACs of approximately 1 kBq/mL, the mean (median) ± standard deviation (range) was − 4% (− 5%) ± 14% (− 28 to 29%) for the avg-AC and − 9% (− 11%) ± 14% (− 33 to 33%) for the max-AC. Lin’s concordance correlation coefficients were ≥ 0.97, indicating substantial AC agreement.ConclusionsQuantification of lesions in the neck region using 124I PET/MR showed acceptable quantitation performance to 124I PET/CT for AC above 1 kBq/mL. The PET/MRI-based 124I ACs in the neck region can be therefore reliably used in pre-therapy dosimetry planning.

Highlights

  • In patients with differentiated thyroid cancer (DTC), serial 124I Positron emission tomography (PET)/computer tomography (CT) imaging is, for instance, used to assess the absorbed dose to lesions

  • Quantitative performance was considered acceptable if the standard deviation (SD) of the percentage differences was ± 25% and the mean value was within ± 10%

  • Lin’s concordance correlation (CC) coefficients were 0.98 and 0.97 for the avg-Activity concentration (AC) and maximum AC (max-AC), respectively, demonstrating substantial AC agreement

Read more

Summary

Introduction

In patients with differentiated thyroid cancer (DTC), serial 124I PET/CT imaging is, for instance, used to assess the absorbed (radiation) dose to lesions. Some clinical studies published so far indicated, on average, discrepant results regarding the ACs or, equivalently, the standard uptake values of corresponding lesions in PET/MR compared to PET/computer tomography (CT) [4, 5] Those studies assumed that the observed differences are mainly due to radiopharmacokinetic properties of the PET tracers used, mainly bound to the short-living radionuclides 18F and 68Ga. Those studies assumed that the observed differences are mainly due to radiopharmacokinetic properties of the PET tracers used, mainly bound to the short-living radionuclides 18F and 68Ga Those authors probably did not “harmonize” PET imaging reconstruction parameters such as voxel size, smoothing level, and the number of effective iterations

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call